Dachaigh › Aillse Prostata › Oregon › Portland
Sgrùdaidhean clionaigeach Aillse Prostata ann an Portland, OR
Tha 33 sgrùdaidhean airson Aillse Prostata a’ lorg phàirtichean aig làraichean ann agus timcheall air Portland (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
A’ fastadhÌre 2
- VA Portland Health Care System, Portland, OR, Portland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Oregon Health & Science University (OHSU), Portland
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
A’ fastadhÌre 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
A’ fastadhÌre 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 mìle air falbh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
A’ fastadhÌre 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
A’ fastadhÌre 4
- Oregon Health & Science University, Portland
Precision-Based Genomics in Prostate Cancer
A’ fastadhSgrùdadh amharc
- Oregon Health Sciences University, Portland
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
A’ fastadhÌre 1
- Oregon Health And Science University, Portland
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
A’ fastadhÌre 1
- Providence Portland Medical Center, Portland
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
A’ fastadhÌre 2
- VA Portland Health Care System, Portland, OR, Portland
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
A’ fastadhÌre 2
- VA Portland Health Care System, Portland, OR, Portland
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
A’ fastadhÌre 3
- VA Portland Health Care System ( Site 0038), Portland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
A’ fastadhÌre 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Kaiser Permanente Northwest, Portland
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
A’ fastadh
- Oregon Health & Science University, Portland
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
A’ fastadhÌre 2
- Oregon Health & Science University, Portland
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
A’ fastadhÌre 1/2
- Research Site, Portland
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
A’ fastadhÌre 3
- Research Site, Portland
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
A’ fastadhÌre 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- agus 1 a bharrachd
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Oregon Health and Science University, Portland
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
A’ fastadhÌre 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- agus 1 a bharrachd
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
A’ fastadhÌre 1/2
- Oregon Health & Science University, Portland
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
A’ fastadhÌre 2
- VA Portland Health Care System, Portland
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
A’ fastadhSgrùdadh amharc
- Oregon Health & Science University Hospital, Portland
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- OHSU Knight Cancer Institute, Portland
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
A’ fastadhÌre 1
- Research Site, Portland
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
A’ fastadh
- OHSU Knight Cancer Institute, Portland
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
A’ fastadh
- OHSU Knight Cancer Institute, Portland
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
A’ fastadhÌre 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- agus 1 a bharrachd
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Oregon Health Sciences University, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Portland
EMBRACE: Exercising Together
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
- OHSU Knight Cancer Institute, Portland
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
A’ fastadhÌre 2
- VA Portland Healthcare System, Portland
Sgrùdaidhean Aillse Prostata ann am bailtean eile
- New York City, NY103 sgrùdaidhean
- Houston, TX76 sgrùdaidhean
- Los Angeles, CA61 sgrùdaidhean
- Boston, MA59 sgrùdaidhean
- St. Louis, MO46 sgrùdaidhean
- Chicago, IL45 sgrùdaidhean
- San Francisco, CA45 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Baltimore, MD43 sgrùdaidhean
- Nashville, TN43 sgrùdaidhean
- Seattle, WA42 sgrùdaidhean
- Washington, DC38 sgrùdaidhean
Sgrùdaidhean eile ann an Portland
- Aillse Sgamhain Neo-chealla-beag46 sgrùdaidhean
- Aillse (gach seòrsa)34 sgrùdaidhean
- Aillse a' bhroilleach33 sgrùdaidhean
- Ailse metastatach29 sgrùdaidhean
- Aillse colorectal28 sgrùdaidhean
- Cancer Ovarian27 sgrùdaidhean
- Ailseachadh nan Sgamhan26 sgrùdaidhean
- Leukemia myeloid geur25 sgrùdaidhean
- Ailse Endometrial24 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil19 sgrùdaidhean
- Cancer Pancreatic19 sgrùdaidhean
- Fàilligeadh a' Chridhe17 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.